|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-12-22
|
|
pubmed:abstractText |
Recent studies have provided strong evidence for the presence of ozone in atherosclerotic lesions. In addition, modification of LDL has been suggested to be involved in atherosclerosis. In the present study we wanted to investigate whether LDL exposed to ozone (ozLDL) is able to modulate the NF-kappaB system, as a paradigm for inflammatory signaling.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
pubmed-author:BrandKorbinianK,
pubmed-author:CappelloChristianC,
pubmed-author:FurmanChristopheC,
pubmed-author:HuthKarin CKC,
pubmed-author:KrautkrämerMartinaM,
pubmed-author:NeumeierDieterD,
pubmed-author:RouisMustaphaM,
pubmed-author:SaugelBerndB,
pubmed-author:SchneiderHeike WHW,
pubmed-author:WieserBiancaB,
pubmed-author:ZwergalAndreasA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
226-32
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17053167-Apoptosis,
pubmed-meshheading:17053167-Atherosclerosis,
pubmed-meshheading:17053167-Cell Line,
pubmed-meshheading:17053167-Dose-Response Relationship, Drug,
pubmed-meshheading:17053167-Endothelium, Vascular,
pubmed-meshheading:17053167-Enzyme Activation,
pubmed-meshheading:17053167-Humans,
pubmed-meshheading:17053167-Interleukin-1 Receptor-Associated Kinases,
pubmed-meshheading:17053167-Lipopolysaccharides,
pubmed-meshheading:17053167-Lipoproteins, LDL,
pubmed-meshheading:17053167-Monocytes,
pubmed-meshheading:17053167-NF-kappa B,
pubmed-meshheading:17053167-Ozone,
pubmed-meshheading:17053167-Phosphorylation,
pubmed-meshheading:17053167-Signal Transduction
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Ozonized low density lipoprotein (ozLDL) inhibits NF-kappaB and IRAK-1-associated signaling.
|
|
pubmed:affiliation |
Institute of Clinical Chemistry and Pathobiochemistry, Technische Universität München, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675 München, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
